Valmark Advisers, Inc. Liquidia Corp Transaction History
Valmark Advisers, Inc.
- $7.6 Billion
- Q3 2025
A detailed history of Valmark Advisers, Inc. transactions in Liquidia Corp stock. As of the latest transaction made, Valmark Advisers, Inc. holds 18,641 shares of LQDA stock, worth $449,434. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,641
Previous 18,641
-0.0%
Holding current value
$449,434
Previous $232,000
84.05%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LQDA
# of Institutions
215Shares Held
47.5MCall Options Held
1.61MPut Options Held
1.15M-
Black Rock Inc. New York, NY4.24MShares$102 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.24MShares$102 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$86.6 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY3MShares$72.3 Million18.2% of portfolio
-
Opaleye Management Inc. Boston, MA2.48MShares$59.7 Million7.37% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.55B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...